NASDAQ
SXTC

China SXT Pharmaceuticals Inc

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

China SXT Pharmaceuticals Inc Stock Price

Vitals

Today's Low:
$0.1114
Today's High:
$0.1162
Open Price:
$0.1146
52W Low:
$0.105
52W High:
$1.18
Prev. Close:
$0.118
Volume:
1579982

Company Statistics

Market Cap.:
$1.66 million
Book Value:
1.285
Revenue TTM:
$1.97 million
Operating Margin TTM:
-266.68%
Gross Profit TTM:
$1.25 million
Profit Margin:
0%
Return on Assets TTM:
-10.42%
Return on Equity TTM:
-38.15%

Company Profile

China SXT Pharmaceuticals Inc had its IPO on 2019-01-04 under the ticker symbol SXTC.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. China SXT Pharmaceuticals Inc has a staff strength of 78 employees.

Stock update

Shares of China SXT Pharmaceuticals Inc opened at $0.11 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.11 - $0.12, and closed at $0.12.

This is a -1.61% slip from the previous day's closing price.

A total volume of 1,579,982 shares were traded at the close of the day’s session.

In the last one week, shares of China SXT Pharmaceuticals Inc have slipped by -1.61%.

China SXT Pharmaceuticals Inc's Key Ratios

China SXT Pharmaceuticals Inc has a market cap of $1.66 million, indicating a price to book ratio of 0.0949 and a price to sales ratio of 0.6231.

In the last 12-months China SXT Pharmaceuticals Inc’s revenue was $1.97 million with a gross profit of $1.25 million and an EBITDA of $-5007957. The EBITDA ratio measures China SXT Pharmaceuticals Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, China SXT Pharmaceuticals Inc’s operating margin was -266.68% while its return on assets stood at -10.42% with a return of equity of -38.15%.

In Q2, China SXT Pharmaceuticals Inc’s quarterly earnings growth was a positive 42.6% while revenue growth was a negative 51.5%.

China SXT Pharmaceuticals Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-0.82 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into China SXT Pharmaceuticals Inc’s profitability.

China SXT Pharmaceuticals Inc stock is trading at a EV to sales ratio of 1.9496 and a EV to EBITDA ratio of 2.4477. Its price to sales ratio in the trailing 12-months stood at 0.6231.

China SXT Pharmaceuticals Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$29.55 million
Total Liabilities
$14.50 million
Operating Cash Flow
$0
Capital Expenditure
$1.03 million
Dividend Payout Ratio
0%

China SXT Pharmaceuticals Inc ended 2024 with $29.55 million in total assets and $0 in total liabilities. Its intangible assets were valued at $29.55 million while shareholder equity stood at $14.69 million.

China SXT Pharmaceuticals Inc ended 2024 with $0 in deferred long-term liabilities, $14.50 million in other current liabilities, 913785.00 in common stock, $-21613133.00 in retained earnings and $0 in goodwill. Its cash balance stood at $17.37 million and cash and short-term investments were $17.37 million. The company’s total short-term debt was $3,390,897 while long-term debt stood at $0.

China SXT Pharmaceuticals Inc’s total current assets stands at $19.52 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $1.58 million compared to accounts payable of $1.38 million and inventory worth $531254.00.

In 2024, China SXT Pharmaceuticals Inc's operating cash flow was $0 while its capital expenditure stood at $1.03 million.

Comparatively, China SXT Pharmaceuticals Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.12
52-Week High
$1.18
52-Week Low
$0.105
Analyst Target Price
$

China SXT Pharmaceuticals Inc stock is currently trading at $0.12 per share. It touched a 52-week high of $1.18 and a 52-week low of $1.18. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.17 and 200-day moving average was $0.33 The short ratio stood at 0.11 indicating a short percent outstanding of 0%.

Around 479.6% of the company’s stock are held by insiders while 38.2% are held by institutions.

Frequently Asked Questions About China SXT Pharmaceuticals Inc

The stock symbol (also called stock or share ticker) of China SXT Pharmaceuticals Inc is SXTC

The IPO of China SXT Pharmaceuticals Inc took place on 2019-01-04

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
$23.19
0.09
+0.39%
$1144.8
-21.6
-1.85%
$0.51
-0.01
-1.35%
$642.05
-35.8
-5.28%
$95.3
-1.02
-1.06%
$116.15
-6.2
-5.07%
ATH-P-E (ATH-P-E)
$25.33
-0.05
-0.2%
$27.53
-0.43
-1.54%
Borosil Limited (BOROLTD)
$407.6
-10.95
-2.62%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

Address

178 North Taidong Road, Taizhou, China, 225300